Create Alert
Watchlist

Remedium Lifecare

₹0.92
-0.02 (2.13%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.95
Prev. Close
0.94
Volume
40,22,036
Total traded value
0.37 Cr
Upper Circuit
1.12
Lower Circuit
0.76

Fundamentals

Market Cap₹83Cr
ROE0.00%
P/E Ratio(TTM)47.00
EPS(TTM)0.02
P/B Ratio0.90
Dividend Yield0.00%
Industry P/E32.93
Book Value1.04
Debt to Equity10.34
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Remedium Lifecare

Remedium Lifecare Limited is a public pharmaceutical company operating across two main business areas: Products and Services, with a focus on trading key pharmaceutical ingredients. Its core philosophy is to achieve business excellence through full transparency and accountability, while conducting its operations in a highly professional and ethical manner. The company's product business involves trading Active Pharmaceutical Ingredients (APIs) and intermediates to both innovative and generic drug makers in domestic and international regulated markets. It aims to improve product quality to secure more orders by leveraging its bargaining power from bulk purchasing to maintain better rates and high productivity. To grow its business and diversify geographically, the company plans to establish two new subsidiaries in Singapore and Mauritius. This focused approach led to a remarkable 403.47% increase in net profit during the 2023-24 financial year compared to the previous year.;
Parent OrganisationRemedium Lifecare Limited
Founded1988
BSE Symbol539561

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Retail And Others
98.87%
Promoters
1.13%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Nykaa - FSN E-Commerce Ventures Ltd.
NA
(0.00%)
702.50
Premier Energies
NA
(0.00%)
33.12
Aegis Logistics
NA
(0.00%)
29.45
Aditya Infotech
NA
(0.00%)
88.29
2025
14
Nov
Quarterly Result
Release date
4
Aug
Quarterly Result
Release date
30
May
Annual Result
Release date

15
Apr
Rights Entitlement
Ex date
61:50
Ratio

61 rights eligible for every 50 existing shares held
Ratio61:50
Offer price₹1.00
Ex date15 Apr ‘25
Record date15 Apr ‘25
Announcement date7 Apr ‘25

7
Apr
Rights Entitlement
Announced
61:50
Ratio

61 rights eligible for every 50 existing shares held
Ratio61:50
Offer price₹1.00
Ex date15 Apr ‘25
Record date15 Apr ‘25
Announcement date7 Apr ‘25
14
Feb
Quarterly Result
Release date
2024
14
Nov
Quarterly Result
Release date
14
Aug
Quarterly Result
Release date
8
Aug
Quarterly Result
Release date

5
Jul
Bonus
Ex date
1:3
Ratio

For every 1 shares you hold, you will receive 3 additional shares
Bonus ratio3:1
Ex date5 Jul ‘24
Record date6 Jul ‘24
Announcement date26 Jun ‘24

26
Jun
Bonus
Announced
1:3
Ratio

For every 1 shares you hold, you will receive 3 additional shares
Bonus ratio3:1
Ex date5 Jul ‘24
Record date6 Jul ‘24
Announcement date26 Jun ‘24
27
May
Annual Result
Release date

23
Feb
Split
Ex date
1:5
Ratio

For each share you hold, you will receive 5 shares with face value of ₹1.0 each
Split Ratio1:5
Ex date23 Feb ‘24
Record date23 Feb ‘24
Announcement date8 Jan ‘24

8
Jan
Split
Announced
1:5
Ratio

For each share you hold, you will receive 5 shares with face value of ₹1.0 each
Split Ratio1:5
Ex date23 Feb ‘24
Record date23 Feb ‘24
Announcement date8 Jan ‘24
Events calendar
View upcoming events in other stocks